Active, not recruitingPhase 2NCT05679570
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
Studying Idiopathic pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International University of Health and Welfare
- Principal Investigator
- Yuichi TamuraInternational University of Health and Welfare
- Intervention
- Satralizumab (Genetical Recombination)(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 20-79 years · All sexes
- Timeline
- 2022 – 2026
Study locations (9)
- Kagoshima University Hospital, Kagoshima, Kagoshima-ken, Japan
- Chiba University Hospital, Chiba, Japan
- Kyushu University Hospital, Fukuoka, Japan
- Kobe University Hospital, Kobe, Japan
- Kurume University Hospital, Kurume, Japan
- Kyorin University Hospital, Mitaka, Japan
- Nagoya University Hospital, Nagoya, Japan
- Hokkaido University Hospital, Sapporo, Japan
- International University of Health and Welfare Mita Hospital, Tokyo, Japan
Collaborators
Japan Agency for Medical Research and Development · Keio University · Chugai Pharmaceutical
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05679570 on ClinicalTrials.govOther trials for Idiopathic pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06829589Retrieval of Economic Incentives and Information on Quality-of-care Indicators in Primary CareFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- RECRUITINGNANCT06605794FreeFlow Percutaneous Atrial Septal Shunt for IPAHShanghai Zhongshan Hospital
- ACTIVE NOT RECRUITINGNCT05723185Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational StudyRovere Querini Patrizia
- RECRUITINGNANCT05584722Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVanderbilt University Medical Center
- RECRUITINGNCT04756076Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension PatientsJiapeng Huang
See all trials for Idiopathic pulmonary arterial hypertension →